NORTHWEST BIOTHERAPEUTICS INC (NWBO) Financials

NWBO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 27.9 million 93.6 million
2023-09-30 31.5 million 96.6 million
2023-06-30 28.4 million 64.1 million
2023-03-31 32.9 million 65.1 million

NWBO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -17.4 million 1.6 million
2023-09-30 -14.4 million 1.6 million
2023-06-30 -12.8 million 278000
2023-03-31 -12.6 million 933000

NWBO Net Income

No data available :(

NWBO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 4.8 million
2023-09-30 - - 4.5 million
2023-06-30 1.4 million 15.7 million 4.8 million
2023-03-31 6.2 million 16.0 million 4.7 million

NWBO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.2 billion
2023-09-30 1.1 billion
2023-06-30 1.1 billion
2023-03-31 1.1 billion

NWBO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 418000 7.5 million 8.1 million -
2023-09-30 437000 7.2 million 7.0 million -
2023-06-30 1.2 million 6.2 million 7.6 million -
2023-03-31 1.3 million 6.9 million 7.0 million -

NWBO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 445000 -
2023-09-30 406000 -
2023-06-30 201000 13.8 million
2023-03-31 880000 13.8 million

NWBO

Price: $0.48

52 week price:
0.40
1.09

Payout Ratio Range:
-3775.51%
-264.29%

Earnings Per Share: -0.06 USD

P/E Ratio: -9.93

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 1.3 million

Ebitda: -69.1 million

Market Capitalization: 654.5 million

Links: